Dorval Allison
SEC insider (Form 3/4/5 filer). CIK 0001625110. Director at PUMA BIOTECHNOLOGY, INC. (PBYI) and 1 other issuer. 18 reported Form 4/5 transactions since Sep 2024; latest on Jun 12, 2026. Located in LOS ANGELES, CA.
Companies Dorval Allison has filed insider reports for
- PUMA BIOTECHNOLOGY, INC. (PBYI): Director
- Verve Therapeutics, Inc. (VERV): Officer, Chief Financial Officer
Dorval Allison
CIK: 0001625110
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (18 total)
- Jun 12, 2026PBYI
PUMA BIOTECHNOLOGY, INC.
SaleDirect11.6K shares at avg. $7.20$84K - Jun 11, 2026PBYI
PUMA BIOTECHNOLOGY, INC.
AwardDirect27K shares- - Jul 25, 2025VERV
Verve Therapeutics, Inc.
Tender OfferDirect13.3K shares- - Jul 25, 2025VERV
Verve Therapeutics, Inc.
DispositionDirectRestricted Stock Units
1.9K shares- - Jul 25, 2025VERV
Verve Therapeutics, Inc.
DispositionDirectRestricted Stock Units
33.8K shares- - Jul 25, 2025VERV
Verve Therapeutics, Inc.
DispositionDirectRestricted Stock Units
45K shares- - Jul 25, 2025VERV
Verve Therapeutics, Inc.
DispositionDirectStock Option (right to buy)
258K shares- - Jul 25, 2025VERV
Verve Therapeutics, Inc.
DispositionDirectStock Option (right to buy)
75K shares- - Jul 25, 2025VERV
Verve Therapeutics, Inc.
DispositionDirectStock Option (right to buy)
180K shares- - Jun 13, 2025PBYI
PUMA BIOTECHNOLOGY, INC.
SaleDirect11.6K shares at avg. $3.40$39K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 12, 2026 |  PBYI PUMA BIOTECHNOLOGY, INC. | Sale | 11,610 | $7.20 | $83,579 | Direct |
| Jun 11, 2026 | PBYI PUMA BIOTECHNOLOGY, INC. | Award | 27,000 | - | $0 | Direct |
| Jul 25, 2025 |  VERV Verve Therapeutics, Inc. | Tender Offer | 13,280 | - | - | Direct |
| Jul 25, 2025 | VERV Verve Therapeutics, Inc. | Disposition Restricted Stock Units | 1,875 | - | - | Direct |
| Jul 25, 2025 | VERV Verve Therapeutics, Inc. | Disposition Restricted Stock Units | 33,750 | - | - | Direct |
| Jul 25, 2025 | VERV Verve Therapeutics, Inc. | Disposition Restricted Stock Units | 45,000 | - | - | Direct |
| Jul 25, 2025 | VERV Verve Therapeutics, Inc. | Disposition Stock Option (right to buy) | 258,000 | - | - | Direct |
| Jul 25, 2025 | VERV Verve Therapeutics, Inc. | Disposition Stock Option (right to buy) | 75,000 | - | - | Direct |
| Jul 25, 2025 | VERV Verve Therapeutics, Inc. | Disposition Stock Option (right to buy) | 180,000 | - | - | Direct |
| Jun 13, 2025 | PBYI PUMA BIOTECHNOLOGY, INC. | Sale | 11,610 | $3.40 | $39,474 | Direct |
1-10 of 18 transactions